Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Spanish Black Radish product · 1 trial · 1 indication
The effect on phase I and phase II enzyme activity determined by measuring plasma and urine acetaminophen metabolite concentrations Subjects will ingest 1000 mg of acetaminophen. Blood will be collected at 0, 2, 4, 6 and 8 hours after acetaminophen dosage for the analysis of plasma acetaminophen metabolites. These measurements will be performed prior to and after 4 weeks of treatment with Spanish Black Radish product.
| Arm | Type | Description |
|---|---|---|
| Spanish Black Radish | EXPERIMENTAL | Spanish Black Radish product |
| Name | Type | Description |
|---|---|---|
| Spanish Black Radish product | DIETARY_SUPPLEMENT | - |
Inclusion Criteria: * Male age 25 - 35 years * BMI 18 - 25 kg/m2 * Healthy as determined by laboratory results, medical history * Agrees to avoid the consumption of cruciferous vegetables for 14 days prior to baseline and during the study treatment period * Has given voluntary, written, informed co...
Spanish Black Radish product is an investigational dietary supplement being studied in healthy volunteers. A Phase 1 pilot study evaluated its efficacy on the induction of Phase I and Phase II enzymes, which are involved in the body's detoxification processes. The study was conducted in Canada and enrolled 20 male participants aged 25 years and older.
Spanish Black Radish product is being developed by Standard BioTools Inc. (ticker: LAB). The company sponsored a Phase 1 clinical trial of the product in healthy volunteers. The study was an open-label, uncontrolled pilot study conducted in Canada.
Spanish Black Radish product is in Phase 1 clinical development. The single Phase 1 trial, NCT02137590, has been completed. The product is investigational and not approved for any medical use. The study enrolled 20 healthy male participants and was not randomized or double-blinded.
Spanish Black Radish product has one completed clinical trial, NCT02137590, titled "An Open Label Pilot Study to Evaluate the Efficacy of Spanish Black Radish on the Induction of Phase I and Phase II Enzymes." The Phase 1 study enrolled 20 healthy male volunteers in Canada, with a minimum age of 25 years.
Spanish Black Radish product is not FDA approved. It is an investigational product that has completed a Phase 1 clinical trial in healthy volunteers. The trial, NCT02137590, was an open-label pilot study conducted in Canada. The product remains in clinical development and has not been approved for any indication.